StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Sanofi (SNY) Reports Board Resignation of Christian Mulliez and Co-Opts Christophe Babule to Board Position
February 6, 2019 4:54 PM
At its meeting held on February 6, 2019, the the Sanofi (NYSE: SNY) Board of Directors duly noted the resignation ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
Management Changes
Next Articles
Sanofi's Board of Directors notes the resignation of Christian Mulliez and co-opts Christophe Babule as Director
February 6, 2019 4:01 PM
Sanofi (SNY) announces FDA approval for Cablivi for adults with aTTP
February 6, 2019 11:50 AM
Sanofi (SNY) Reports Isatuximab Phase 3 Trial Meets Primary Endpoint of Prolonging Progression Free Survival in Patients with Relapsed/Refractory Multiple Myeloma
February 5, 2019 5:45 AM
UPDATE: Sanofi (SNY), Regeneron (REGN) Report CHMP Recommends Approval of Praluent (alirocumab) to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease
February 4, 2019 5:56 AM